Clinical Trial Update: Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study sponsored by GlaxoSmithKline to assess the effects of SRT2104 and prednisolone on blood biomarkers in healthy volunteers; chronic obstructive pulm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Prednisolone (Prednisolone)
• SRT2104 (SRT2104)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED